Outpatient allogeneic hematopoietic stem-cell transplantation: a review.
Guillermo José Ruiz ArgüellesAndrés Gómez-De LeónPerla R Colunga-PedrazaOlga G Cantú-RodríguezCésar Homero Gutierrez-AguirreGuillermo Ruíz-ArguellesPublished in: Therapeutic advances in hematology (2022)
Hematopoietic stem-cell transplantation (HSCT) is usually performed in well-equipped units inside a hospital. The cost of this in-hospital transplant is usually very high; therefore, this procedure is more difficult to perform in low- and middle-income countries. Autologous outpatient HSCT is now a common procedure; however, outpatient allogeneic transplants are more complicated. Only a few centers in the world have incorporated outpatient HSCT. This transplant requires special adaptation, like a day hospital, careful selection of patients, oral medications, and the patient must live relatively close to the hospital. The results until now suggest that this outpatient transplant is factible and similar to inpatient HSCT. The objective was to review and describe the different methods and results following an outpatient allogeneic-HSCT strategy.
Keyphrases
- hematopoietic stem cell
- allogeneic hematopoietic stem cell transplantation
- acute care
- healthcare
- bone marrow
- stem cell transplantation
- end stage renal disease
- adverse drug
- chronic kidney disease
- acute lymphoblastic leukemia
- minimally invasive
- newly diagnosed
- mental health
- palliative care
- ejection fraction
- stem cells
- mesenchymal stem cells
- case report
- peritoneal dialysis
- patient reported